You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 March 2026 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Tuesday announced a definitive agreement to acquire privately held Corstasis Therapeutics Inc, adding Enbumyst (bumetanide nasal spray) to its car...
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (now Bristol Myers Squibb), within the oncology the...
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...
2 March 2026 - Life science company ValiRx PLC (AIM: VAL) revealed on Monday that it has established a wholly owned subsidiary, ValiRx Animal Health Limited, to develop and commercialise its oncology assets within the veterinary market.The new entity...
2 March 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that Japan's Ministry of Health, Labour and Welfare has granted orphan drug designation to rilzabrutinib, its oral, reversible covalent Br...
2 March 2026 - Molecular diagnostics company Novacyt S.A. (EURONEXT GROWTH: ALNOV) (AIM: NCYT) announced on Monday that, further to its 23 February 2026 notification, its wholly owned subsidiary, Novacyt Holdings UK Limited, has completed the acquisi...